Brief Summary
The objective of the study is to evaluate efficacy and safety of zanzalintinib in participants with recurrent or progressive meningioma refractory to standard therapies.
Protocol Interventions
Drug: Zanzalintinib
- Make an AppointmentAppointments
Make an Appointment
Let Siteman's care coordinators guide you through your next best step. Their oncology expertise means you are in good hands.Start with Siteman
Talk With Us
Currently in Treatment at Siteman